205P VERITAC update: Phase II study of ARV-471, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader in ER+/human epidermal growth factor receptor 2 (HER2)- advanced breast cancer

Autor: Hurvitz, S.A., Schott, A., Ma, C.X., Nanda, R., Zahrah, G., Hunter, N., Tan, A., Telli, M.L., Anampa, J., Jeselsohn, R., Munster, P., Zhi, E., Gedrich, R., Mather, C., Han, H., Hamilton, E.

Publikováno v: In ESMO Open May 2023 8(1) Supplement 4

HOLA COVID-19 Study: Evaluating the Impact of Caring for Patients With COVID-19 on Cancer Care Delivery in Latin America.

Autor: Bernabe-Ramirez C; Essen Health Care, Bronx, NY., Velazquez AI; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA.; National Clinician Scholars Program, Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, CA., Olazagasti C; Sylvester Comprehensive Cancer Center at the University of Miami, Miami, ML., Decat Bergerot C; Centro de Câncer de Brasília (CETTRO), Brasília, DF, Brazil., Bergerot PG; Centro de Câncer de Brasília (CETTRO), Brasília, DF, Brazil., Corona Cruz J; Instituto Nacional de Cancerologia (INCan), Mexico City, Mexico., Riano I; Hematology and Oncology Section, Dartmouth-Hitchcock Medical Center, Lebanon, NH., Adaniel C; Clinica Alemana, Santiago, Chile., Ramirez F; SOLCA, Instituto Oncologico Nacional, Guayaquil, Ecuador., Anampa J; Montefiore Medical Center/Albert Einstein College of Medicine/Albert Einstein Cancer Center, Bronx, NY., Cajina C; Universidad Nacional Autonoma de Nicaragua, Managua, Nicaragua., Mena E; Instituto Nacional Del Cancer Rosa Emilia Sanchez Perez de Tavares (INCART), Santo Domingo, Dominican Republic., Gracia E; National Institute of Oncology and Radiobiology, Havana City, Cuba., Menendez A; Hartford Healthcare, Hartford, CT., Idrovo H; Universidad del Valle, Cali, Colombia., Bezares R; Hospital Teodoro Alvarez Caba, Buenos Aires, Argentina., Castillo Fernandez OO; Instituto Oncologico Nacional, Panama City, Panama., Duque L; Hospital Universitario Dr Jose Maria Vargas, Caracas, Venezuela., Corrales-Rodríguez L; Clinical Oncology Department, Hospital San Juan de Dios, San José, Costa Rica., Ramos G; SOLCA, Instituto Oncologico Nacional, Guayaquil, Ecuador., Kihn-Alarcón AJ; Research Department, Liga Nacional Contra el Cáncer & Instituto de Cancerología, Guatemala City, Guatemala., Schlam I; Tufts Medical Center, Boston, MA., Bruno X; Hematology Oncology Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Umanzor G; Centro Oncologico Integral in San Pedro Sula, Honduras., Castro JL; Department of Medical Oncology, Oncology Hospital, Salvadoran Institute of Social Security, Rosales National Hospital, San Salvador, El Salvador., Losco F; Instituto Alexander Fleming, Ciudad Autónoma de Buenos Aires, Argentina., Ubillos L; Hospital de Clínicas, Montevideo, Uruguay., Richardet E; Instituto Oncológico De Córdoba, Córdoba, Argentina., Soto-Perez-de-Celis E; Department of Geriatrics, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico., Duma N; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.

Publikováno v: JCO global oncology [JCO Glob Oncol] 2022 Mar; Vol. 8, pp. e2100251.

Monitoring the Response of Cyclin-Dependent Kinase 4/6 Inhibitors with Mean Corpuscular Volume.

Autor: Kurt İnci, Bediz¹ (AUTHOR) bedizkurt@gmail.com, Kubilay Tolunay, Pınar¹ (AUTHOR), Öztekin, Şura¹ (AUTHOR), Aydemir, Ergin¹ (AUTHOR), Öner, İrem¹ (AUTHOR), Ateş, Öztürk¹ (AUTHOR), Karaçin, Cengiz¹ (AUTHOR)

Publikováno v: Current Oncology. Oct2024, Vol. 31 Issue 10, p5722-5729. 8p.

Baohuoside I chemosensitises breast cancer to paclitaxel by suppressing extracellular vesicle/CXCL1 signal released from apoptotic cells.

Autor: Wang, Shengqi^1,2,3,4,5,6 (AUTHOR), Li, Jing^3,4 (AUTHOR), Xu, Shang^3,4 (AUTHOR), Wang, Neng^4,6,7 (AUTHOR), Pan, Bo^3,4 (AUTHOR), Yang, Bowen^3,4 (AUTHOR), Zheng, Yifeng^1,3,4,6 (AUTHOR), Zhang, Juping^1,3,4,6 (AUTHOR), Peng, Fu⁸ (AUTHOR), Peng, Cheng² (AUTHOR) pengchengchengdu@126.com, Wang, Zhiyu^1,3,4,5,6 (AUTHOR) wangzhiyu@gzucm.edu.cn

Publikováno v: Journal of Extracellular Vesicles. Jul2024, Vol. 13 Issue 7, p1-27. 27p.

Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer.

Autor: Anampa J; Department of Oncology, Section of Breast Medical Oncology, Montefiore Medical Center, NY, USA janampa@montefiore.org., Haque T; Department of Oncology, Section of Breast Medical Oncology, Montefiore Medical Center, NY, USA., Murakhovskaya I; Department of Oncology, Division of Hematology, Montefiore Medical Center, NY, USA., Wang Y; Department of Pathology, Montefiore Medical Center, NY, USA., Bachiashvili K; Department of Oncology, Section of Breast Medical Oncology, Montefiore Medical Center, NY, USA., Papazoglu C; Department of Oncology, Section of Breast Medical Oncology, Montefiore Medical Center, NY, USA., Pradhan K; Department of Developmental & Molecular Biology, NY, USA., Steidl UG; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA., Sparano JA; Department of Oncology, Section of Breast Medical Oncology, Montefiore Medical Center, NY, USA., Verma A; Department of Oncology, Division of Hematology, Montefiore Medical Center, NY, USA.; Department of Developmental & Molecular Biology, NY, USA.

Publikováno v: Haematologica [Haematologica] 2018 Mar; Vol. 103 (3), pp. e98-e102. Date of Electronic Publication: 2017 Nov 30.